Paracetamol or Ibuprofen in the Primary Prevention of Asthma in Tamariki (PIPPA Tamariki).

Phase 4

Recruiting

• Conditions: Asthma; Bronchiolitis; Viral induced wheeze; Eczema; Atopy; Respiratory - Asthma; Skin - Dermatological conditions; Inflammatory and Immune System - Allergies; Respiratory - Other respiratory disorders / diseases; Infection - Other infectious diseases

• Registration Number: ACTRN12618000303246
• Lead Sponsor: Auckland District Health Board

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2018-02-28
• Last Update Posted: 16 March 2020

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 3922

Inclusion Criteria

1. Birth within Auckland and Wellington regions.
2. Age <8 weeks (chronological age).

Exclusion Criteria

Infants will not be enrolled if ANY of the following apply:
1. Parent is unable to give informed consent for participation in the trial;
2. Highly unlikely to remain in New Zealand for the first 6 years of life;
3. Chronic disease associated with limited life expectancy (i.e., less than 6 years);
4. Gestational age at birth <32 weeks;
5. Previous exposure to paracetamol or ibuprofen since birth.

Study & Design

• Study Type: Interventional
• Study Design: Not specified